User login

Tai discusses TRIPS waiver, vaccine production with Pfizer, AstraZeneca

April 26, 2021 at 9:39 PM
U.S. Trade Representative Katherine Tai spoke with the top executives of Pfizer and AstraZeneca on Monday about a proposed waiver of obligations to the Agreement on Trade-Related Aspects of Intellectual Property, where the ambassador expressed “deep sympathy” for the people of India, where COVID-19 deaths have reached alarming rates in recent days. Tai spoke with Pfizer CEO Albert Bourla and AstraZeneca Executive Vice President and Head of U.S. Business Ruud Dobber on Monday evening about “increasing vaccine production, global health...

Not a subscriber? Sign up for 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.